Authors
AR Aliabadi, Sarikapan Wilailak, Orla McNally, Jonathan S Berek, Aparna Sridhar, FIGO Committee on Contraception, FIGO Committee on Women's Cancer, Jill Sheffield, Asha Kasliwal, Jotham Musinguzi, Cuauhtemoc Celis González, Azra Ahsan, Glen Mola, Priyankur Roy, Wai‐cheung Lam, Miguel Antonio Guidos Serrano, Ian Askew, Petra Ten Hoope‐Bender, Nichole Tyson, John Townsend, Anita Makins, Nomi Fuchs‐Montgomery, Bethan Cobley, Sean Kehoe, Tali Pomerantz, Gerhard Lindeque, Rose Anorlu, Giovanni Scambia, Aikou Okamoto, Barbara Schmalfeldt, Rene Pareja, Jonathan Berek, Carien Creutzberg, David Mutch, Xavier Matias‐Guiu, Christina Fotopoulou
Publication date
2024/5/9
Source
International Journal of Gynecology & Obstetrics
Description
Reproductive cancers, encompassing various malignancies like endometrial, ovarian, cervical cancer, and gestational trophoblastic neoplasia, pose a significant global health burden. Understanding their patterns is vital for effective prevention and management. Contraceptives show a protective effect against some of these cancers. This clinical guidance document aims to elucidate the disease burden of reproductive cancers and the evidence supporting contraceptive methods in prevention and management. Regional disparities in incidence and mortality highlight the urgent need for targeted interventions, particularly in low‐resource settings. Healthcare providers must weigh individual risk profiles and medical eligibility criteria when discussing contraceptive options. Enhanced health literacy through direct patient education is essential for leveraging low‐cost behavioral interventions to mitigate reproductive …
Scholar articles
AR Aliabadi, S Wilailak, O McNally, JS Berek, A Sridhar… - International Journal of Gynecology & Obstetrics, 2024